Last updated: February 27, 2022
Sponsor: University of Aarhus
Overall Status: Active - Recruiting
Phase
N/A
Condition
Diet And Nutrition
Crohn's Disease
Inflammatory Bowel Disease
Treatment
N/AClinical Study ID
NCT05271838
1-10-72-363-21
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age 18 years or older
- Cognizant
- Must speak or read Danish or participate in relevant communication in interpreting ortranslating the study material.
- Diagnosed with Acute Severe Ulcerative Colitis (ASUC) (documented in the patientjournal)
- Admitted at "Lever-, Mave-, og Tarmsygdomme/ LMT" at Aarhus University Hospital and inmedical treatment with high-dose intravenous steroid (Solumedrol 40 mg x 2 daily)
Exclusion
Exclusion Criteria:
- Pregnant and/or lactating women
- Plasma creatinine > 200 µmol/L (protein intervention only)
- Patients receiving tube- or parenteral feeding (protein intervention only)
- Receiving any kind of magnesium supplementation 6 months prior to inclusion (magnesiumintervention only)
- Diagnosed with Type 1 or Type 2 Diabetes Mellitus (observational part only)
Study Design
Total Participants: 36
Study Start date:
February 08, 2022
Estimated Completion Date:
July 01, 2022
Study Description
Connect with a study center
Aarhus University Hospital
Aarhus N, 8200
DenmarkActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.